Nicorandil augments regional ischemia-induced monophasic action potential shortening and potassium accumulation without serious proarrhythmia

Journal of Cardiovascular Pharmacology
T MiyazakiS Ogawa

Abstract

Nicorandil is a clinically used nitrovasodilator that has a property as an opener of ATP-sensitive potassium (KATP) channels in vitro. We examined whether nicorandil at a clinically used dose augmented regional ischemia-induced monophasic action potential (MAP) shortening and increase in extracellular potassium concentration ([K+]o), and how it affected arrhythmia occurrence. Five-minute occlusion of a distal site of the left anterior descending coronary artery (LAD) was repeated at 30-min intervals in anesthetized open-chest dogs while recording MAP or measuring [K+]o with a potassium-sensitive valinomycin electrode from the epicardial center of the ischemic myocardium. Nicorandil (0.2-0.5 mg/kg) was administered intravenously (i.v.) 5 min before the third occlusion, and the data were compared with those during the second occlusion (control). During the second occlusion, MAP duration at 90% repolarization (APD90) shortened (mean rate for 5 min, 13 +/- 3%, n = 11) and [K+]o increased from 3.7 +/- 0.1 to 6.2 +/- 0.8 mM at 5 min (n = 12). These changes were reversed < or = 3 min after reperfusion. Before the third occlusion, baseline APD90 and [K+]o were not altered by nicorandil; however, the extent of occlusion-induced shorteni...Continue Reading

Citations

Jun 15, 2005·Journal of Molecular and Cellular Cardiology·A Jahangir, Andre Terzic
Aug 26, 2000·European Journal of Pharmacology·W A CoetzeeM Avkiran
Nov 6, 2001·Journal of the American College of Cardiology·A OkamuraT Ogihara
Sep 5, 2013·Cardiovascular Intervention and Therapeutics·Maki OiTakeshi Kimura
Jun 19, 2009·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Masato NishimuraToshihiko Ono
Nov 6, 2012·Pacing and Clinical Electrophysiology : PACE·Hui-Ling LeeDelon Wu
Jan 26, 2010·Journal of Molecular and Cellular Cardiology·Yanggan Wang, Joseph A Hill
Feb 5, 2002·Expert Opinion on Pharmacotherapy·A JahangirW K Shen
Dec 15, 2015·Physiological Reviews·Monique N Foster, William A Coetzee
Aug 11, 2017·Internal Medicine·Shun MorishitaIchiro Shiojima
Jul 15, 2015·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Naoko Matsushita, Masamichi Hirose

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antianginal Drugs: Mechanisms of Action

Antianginal drugs, including nitrates, beta-blockers, and calcium channel blockers, are used in the treatment of angina pectoris. Here is the latest research on their use and their mechanism of action.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.